Does hypnotherapy work for IBS? Meta-analytic evidence

Gut-directed hypnotherapy (GDH) is one of the best-evidenced non-drug treatments for irritable bowel syndrome. Independent randomised trials over four decades show that a substantial share of patients get clinically meaningful symptom relief. This page summarises the pooled evidence, and the limits that sit beside it.

Key evidence

The Flik et al. (2014) meta-analysis pooled randomised trials of hypnotherapy for IBS and found a positive effect on global symptoms and abdominal pain. The review also flagged small study sizes and uneven methodological quality in some included trials.

A later Gut network meta-analysis of psychological therapies for IBS compared several brain–gut behaviour therapies in one network. GDH sits among the better-supported psychological options in that analysis. The paper is a review of psychological therapies as a class. It is not a claim that one named author “ranked GDH first versus CBT.”

Landmark single-trial support starts with the Whorwell 1984 gut-hypnosis RCT. Later groups in the United Kingdom, Europe, and elsewhere replicated benefit at 12 months. See long-term follow-up.

NICE CG61 (irritable bowel syndrome in adults) lists psychological interventions, including hypnotherapy, for people whose symptoms persist after first-line care. That is UK IBS guidance. It is not NICE NG116, which is a PTSD guideline.

Limitations

Participants know they received hypnotherapy. Expectancy cannot be fully excluded. Trials against supportive therapy tend to show smaller effects than waitlist comparisons. Some older trials used Manning or Rome II criteria rather than Rome IV.

What we don't know yet

Subtype-specific effects (IBS-D versus IBS-C versus mixed) are thinner than the pooled global-symptom signal. Cost-effectiveness outside European health systems, including Australia, is not well estimated. See what we don't know.

This page is informational only. It is not personal medical advice.